Interestingly, our recent pan-cancer analysis of The Cancer Genome Atlas (TCGA) datasets also confirmed that PRDM1 gene is often genetically altered in DLBCL, with 8.2% mutation frequency [45]. The gene discussed is PRDM1; the disease is cancer.